GNLX logo

Genelux Corporation

GNLX
Healthcare|Biotechnology|US
$1.96
+0.14 (+7.69%)
Tangible Book / Share
$0.36
Cash / Share
$0.42
Next Earnings Report
Nov 11, 2026
EPS est. -$0.20
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Mar 19, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (3)

Dec 2026
Est. completion
P3Platinum-resistant Ovarian Cancer
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
NCT05281471n=186
Dec 2026
Est. completion
P1P2SCLC, Extensive Stage
Olvi-Vec Combined With Platinum Plus Etoposide Therapy in Patients With Late Phase SCLC
NCT07136285n=27
Feb 2027
Est. completion
P2Advanced Non-squamous Non-small-cell Lung Cancer
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
NCT06463665n=142

Recent Press Releases

Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy
Sep 9, 2026 · GlobeNewsWire
Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates
Aug 13, 2026 · GlobeNewsWire

SEC Filings (37)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 4, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Jun 22, 20268-KMaterial eventDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
Apr 29, 2026ARSAnnual report to holdersDocumentIndex
Apr 29, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 29, 2026DEF 14AProxy / shareholder voteDocumentIndex
Mar 19, 2026424B5Offering prospectusDocumentIndex
Mar 19, 2026S-8Employee stock planDocumentIndex
Mar 19, 20268-KMaterial eventDocumentIndex
Mar 19, 202610-KAnnual reportDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 2, 20268-KMaterial eventDocumentIndex
Jan 8, 20268-KMaterial eventDocumentIndex
Jan 8, 2026424B5Offering prospectusDocumentIndex
Jan 7, 2026424B5Offering prospectusDocumentIndex
Jan 5, 20268-KMaterial eventDocumentIndex
Jan 2, 20268-KMaterial eventDocumentIndex
Nov 14, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 5, 202510-QQuarterly reportDocumentIndex
Sep 3, 20258-KMaterial eventDocumentIndex
Aug 7, 2025S-8Employee stock planDocumentIndex
Aug 7, 202510-QQuarterly reportDocumentIndex
Jul 25, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Jul 11, 2025ARSAnnual report to holdersDocumentIndex
Jul 11, 2025DEFA14AProxy / shareholder voteDocumentIndex
Jul 11, 2025DEF 14AProxy / shareholder voteDocumentIndex
May 6, 202510-QQuarterly reportDocumentIndex
Apr 29, 202510-K/AAnnual reportDocumentIndex
Mar 28, 2025S-8Employee stock planDocumentIndex
Mar 28, 202510-KAnnual reportDocumentIndex
Mar 25, 2025424B5Offering prospectusDocumentIndex
Mar 25, 20258-KMaterial eventDocumentIndex
Mar 25, 2025FWPDocumentIndex
Mar 25, 20258-KMaterial eventDocumentIndex
Feb 3, 20258-KMaterial eventDocumentIndex
Nov 14, 202410-QQuarterly reportDocumentIndex